Alveolar macrophage interactions with Pneumocystis carinii

Journal of Laboratory and Clinical Medicine

Volumn 133, Issue 6, 1999, Pages 535-540

  Vassallo, Robert ^b   Thomas Jr , Charles F ^b   Vuk Pavlovic, Zvezdana ^b   Limper, Andrew H ^a  

^a MAYO CLINIC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0033152986     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(99)90182-8     Document Type: Conference Paper

References (35)

1. 1. Fauci AS, Macher AM, Longo DL, Lane HC, Rook AH, Masur H, et al. NIH conference. Acquired immune deficiency syndrome: epidemiologic, clinical, immunologie, and therapeutic considerations. Ann Intern Med 1984;100:92-106.
2. 2. Shellito J, Warnock ML, Curtis JL, Sniezek MJ, Arraj-Peffer SM, Kaltreider HB, et al. Inflammatory responses to Pneumocystis carinii in mice selectively depleted of helper T lymphocytes. Am J Resp Cell Mol Biol 1991;5:186-97.
3. 3. Harmsen AG, Stankiewicz M. Requirement of CD4+ cells in resistance to Pneumocystis carinii in mice. J Exp Med 1990;172:937-45.
4. 4. Masur H, Jones TC, The interaction in vitro of Pneumocystis carinii with macrophages and L-cells. J Exp Med 1978;147:157-70.
5. 5. Von Kehren LA, Pesanti EL. Uptake and degradation of Pneumocystis carinii by macrophages in vitro. Rev Respir Dis 1978;118:1051-9.
6. 6. Pottratz ST, Martin WJ. Mechanism of Pneumocystis carinii attachment to cultured rat alveolar macrophages. J Clin Invest 1990;86:1678-83.
7. 7. Koziel H, Eichbaum Q, Kruskal BA, Pinkston P, Rogers RA, Armstrong WYK, et al. Reduced binding and phagocytosis of Pneumocystis carinii by alveolar macrophages from persons infected with HIV-1 correlates with macrophage mannose receptor downregulation. J Clin Invest 1998;102:1332-44.
8. 8. Limper AH, Standing JE, Hoyte JS. Alveolar macrophages mediate Pneumocystis carinii degradation and organism clearance from the lung. J Clin Invest 1997;99:2110-7.
9. 9. Garraud O, Faucher A, Legrand E. Impairment of monocyte function in advanced head and neck cancer. Immunol Lett 1988;18:213-8.
10. 10. Berg JT, Lee ST, Thepen T, Lee CY, Tsan MF. Depletion of alveolar macrophages by liposome-encapsulated dichloromethylene diphosphonate. J Appl Physiol 1993;74:2812-9.
11. 11. Ezekowitz RAB, Williams DJ, Koziel H, Armstrong MYK, Warner A, Richards FF, et al. Uptake of Pneumocystis carinii mediated by the macrophage mannose receptor. Nature 1991;351:155-8.
12. 12. Lundgren B, Lipchik GY, Kovacs JA. Purification and characterization of a major human Pnceumocystis carinii surface antigen. J Clin Invest 1991;87:163-70.
13. 13. O'Riordan DM, Standing JE, Limper AH. Pneumocystis carinii glycoprotein A binds macrophage mannose receptors. Infect Immun 1995;63:779-84.
14. 14. Hoffman OA, Standing JE, Limper AH. Pneumocystis carinii stimulates tumor necrosis factor-α release from alveolar macrophages through a β-glucan mediated mechanism. J Immunol 1993;150:3932-40.
15. 15. Neese LW, Standing JE, Olson HJ, Castro M, Limper AH. Vitronectin, fibronectin, and gp120 enhance macrophage release of TNF-alpha in response to Pneumocystis carinii. J Immunol 1994;152:4549-56.
16. 16. Limper AH, Standing JE, Hoffman OA, Castro M, Neese LW. Vitronectin binds to Pneumocystis carinii and mediates organism attachment to cultured lung epithelial cells. Infect Immun 1993;61:4302-9.
17. 17. O'Riordan DM, Standing JE, Kwon KJ, Chang D, Crouch EC, Limper AH. Surfactant protein D interacts with Pneumocystis carinii and mediates organism adherence to alveolar macropahges. J Clin Invest 1995;95:2699-710.
18. 18. Castro M, Morgenthaler TI, Hoffman OA, Rohrbach MS, Limper AH. Pneumocystis carinii induces the release of arachidonic acid and its metabolites from alveolar macrophages. Am J Resp Cell Mol Biol 1993;9:73-81.
19. 19. Chen W, Havell EA, Harmsen AG. Importance of tumor necrosis factor-alpha and gamma Interferon in host resistance against Pneumocystis carinii infection. 1992;60:1279-84.
20. 20. Kolls JK, Lei D, Vazquez C, Odorn G, Summer WR, Nelson S, et al. Exacerbation of murine Pneumocystis carinii infection by adeno-viral mediated gene transfer of a TNF inhibitor. Am J Resp Cell Mol Biol 1997;16:112-8.
21. 21. Rudmann DC, Preston AM, Moore MW, Beck JM. Susceptibility to Pneumocystis carinii in mice is dependent on simultaneous deletion of IFN-γ and type 1 and 2 TNF receptor genes. J Immunol 1998;161.360-6.
22. 22. Olson EJ, Standing JE, Griego-Harper N, Hoffman OA, Limper AH. Fungal β-glucan interacts with vitronectin and stimulates tumor necrosis factor-α release from macrophages. Infect Immun 1996;64:3548-54.
23. 23. Vassallo R, Standing JE, Limper AH. Beta-glucan from Pneumocystis carinii cell wall stimulates TNF-α release from alveolar macrophages. J Invest Mod 1998;46:256A.
24. 24. Yu MY, Limper AH. Pneumocystis carinii induces intercellular adhesion molecule-1 expression in lung epithelial cells through tumor necrosis factor-α mediated mechanisms. Am J Physiol 1997;273:L1103-11.
25. 25. Pesanti EL. Interaction of cytokines and alveolar cells with Pneumocystis carinii in vitro. J Infect Dis 1991;163:611-6.
26. 26. Benfield TL, Vestbo J, Junge J, Nielsen TL, Jensen A, Lundgren JD. Prognostic value of interleukin-8 in AIDS-associated Pneumocystis carinii pneumonia. Am J Respir Crit Care Med 1995;151:1058-62.
27. 27. Denis M, Ghadirian H. Deregulation of interleukin-8, interleukin-10, and interleukin-12 release by alveolar macrophages from HTV type-1 infected subjects. AIDS Res Hum Retroviruses 1994;10:1619-27.
28. 28. Hidalgo HA, Helmke RJ, German VF, Mangos JA. Role of the zymolyase-sensitive cyst wall of Pneumocystis carinii in the oxidative hurst of macrophages. J Protozool 1991;8:30S-1.
29. 29. Limper AH, O'Riordan DM, Vuk-Pavlovic Z, Crouch E. Accumulation of surfactant protein-D in the lung during Pneumocystis carinii pneumonia. J Eukaryot Microbiol 1994;41:98S.
30. 30. Kuroki Y, Voelker DR. Pulmonary surfactant proteins. J Biol Chem 1994;269:25943-6.
31. 31. Phelps DS, Rose RM. Increased recovery of surfactant protein A in AIDS-relatecl pneumonia. Am Rev Respir Dis 1991;143:1072-5.
32. 32. Zimmerman PE, Voelker DR, McCormack FX, Paulsrud JR, Martin WJ. 120-kD surface glycoprotein of Pneumocystis carinii is a ligand for surfactant protein A. J Clin Invest 1992;89:143-9.
33. 33. Williams MD, Wright JR, March KL, Martin WJ. Human surfactant protein A enhances attachment of Pneumocystis carinii to rat alveolar macrophages. Am J Resp Cell Mol Biol 1996;14:232-8.
34. 34. Koziel H, Phelps DS, Fishman JA, Armstrong MYK, Richards FF, Rose RM. Surfactant protein A reduces binding and phagocytosis of Pneumocystis carinii by human alveolar macrophages in vitro. Am J Respir Cell Mol Biol 1998;18:834-43.
35. 35. Limper AH, O'Riordan DM, Standing JE, Crouch EC. Surfactant protein D modulates macrophage release of TNF-α in response to Pneumocystis carinii and LPS. Am J Respir Crit Care Med 1994;149:A982.